Scientists have used a three GeV synchrotron radiation facility to visualize an interaction between gluten and T-cells in the human immune system, providing insight into how celiac disease is triggered. And it will lead to a vaccine, they believe.
An increasingly diagnosed chronic inflammatory disorder, celiac disease affects the digestive process of the small intestine. When a person with celiac disease consumes gluten, a protein found in wheat, rye and barley, their immune system triggers T-cells to fight the offending proteins, which damages the small intestine and inhibits absorption of important nutrients into the body. There are no treatments, apart from making sure to eat no foods with gluten.
About half the population is genetically susceptible to celiac disease because they carry the immune response genes HLA-DQ2 or HLA-DQ8. One in 20 people who carry HLA-DQ2 and about one in 150 who have HLA-DQ8 may develop celiac disease, but people with other versions of the HLA-DQ genes will not.
The researchers used the Australian Synchrotron to visually determine how T-cells of the immune system interact with gluten. Unlike an accelerator such as the LHC, the Australian Synchroton is a light source rather than a collider, making it ideal for the new study. The end goal of the project is to produce a treatment which allows celiac sufferers to resume a normal diet.
Knowing which genes were likely to be risk factors but now what variables determined celiac disease led researchers Drs. Hugh Reid and Professor Jamie Rossjohn of Monash University, Professor Frits Koning of the University of Leiden and Dr. Bob Anderson of biotechnology company ImmusanT Inc., to examine how the immune system senses gluten. They believe they have found an important breakthrough.
"This is the first time that the intricacies of the interaction between gluten and two proteins that initiate immune responses have been visualised at a sub-molecular level," Reid said.
ImmusanT is developing a blood test and a therapeutic vaccine, Nexvax2®, for patients with celiac disease who carry the gene HLA-DQ2. It is intended to restore immune tolerance for gluten and thus allow patients to again include gluten in their diet. Future studies will investigate whether T-cell activation by gluten in patients with HLA-DQ2 follows similar principles as observed in this study that focused on HLA DQ8 mediated celiac disease.
Anderson, Chief Scientific Officer at ImmusanT, says the research presents a unique opportunity.
"Because we now know the gluten peptides responsible for coeliac disease, we can interrogate the molecular events leading to a self-destructive immune response."
Research published in Immunity
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- A Billion Years Ago, What Did Earth's Ancient Magnetic Field Look Like?
- How A Former Naturopath Can Help Unravel The Trickery of Alternative Medicine
- Can A New Rule Trigger A Second EU Referendum? Petition Signatures Over 11% Of Total Votes Cast
- Insects Were Already Using Camouflage 100 Million Years Ago
- Finding All-Hadronic Top - Again
- Better Brains With Beer
- Some Celiac Disease May Be Due To Viruses
- "Thanks for your understanding!Cheers,T...."
- "As for comparing America and Europe, I am reminded of “Pyramid” by Robert Abernathy.  ..."
- "Just a link to add to this article at some point. A good Google document about the sorts of issues..."
- "Oh, okay - there's no reason for them to add up, indeed it's a bit of a coincidence that it turned..."
- "Robert, Out of curiosity I added totalled the Ashcroft figures of both Leave and Remain age groups..."
- Researchers open new path of discovery in Parkinson's disease
- A shampoo bottle that empties completely -- every last drop
- Radioactive cesium fallout on Tokyo from Fukushima concentrated in glass microparticles
- Meet the biohackers
- Seeds of black holes could be revealed by gravitational waves detected in space